Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function

Insulin resistance condition is associated to the development of several syndromes, such as obesity, type 2 diabetes mellitus and metabolic syndrome. Although the factors linking insulin resistance to these syndromes are not precisely defined yet, evidence suggests that the elevated plasma free fatty acid (FFA) level plays an important role in the development of skeletal muscle insulin resistance. Accordantly, in vivo and in vitro exposure of skeletal muscle and myocytes to physiological concentrations of saturated fatty acids is associated with insulin resistance condition. Several mechanisms have been postulated to account for fatty acids-induced muscle insulin resistance, including Randle cycle, oxidative stress, inflammation and mitochondrial dysfunction. Here we reviewed experimental evidence supporting the involvement of each of these propositions in the development of skeletal muscle insulin resistance induced by saturated fatty acids and propose an integrative model placing mitochondrial dysfunction as an important and common factor to the other mechanisms

Metabolic regulation and production of oxygen reactive species during muscule contraction: effect of glycogen on intracellular redox state

O exercício físico prolongado reduz os estoques de glicogênio muscular. Nessas condições, os processos de fadiga muscular são estimulados coincidindo com um aumento na produção de espécies reativas de oxigênio. A suplementação de carboidratos ou de antioxidantes isoladamente contribui para a melhora da performance muscular, sugerindo um efeito importante da depleção de substrato (glicose) e do aumento da produção de EROs no desenvolvimento da fadiga muscular durante a atividade física. Embora o mecanismo seja desconhecido, estamos propondo neste estudo que uma maior disponibilidade de glicogênio poderia favorecer uma maior atividade da via das pentoses fosfato, aumentando a disponibilidade de NADPH e GSH no tecido muscular esquelético. Uma maior capacidade antioxidante aumentaria a capacidade do tecido muscular em atividade, mantendo o equilíbrio redox durante atividade física prolongada e melhorando o desempenho. Neste processo, o ciclo glicose-ácido graxo pode ser importante aumentando a oxidação de lipídio e reduzindo o consumo de glicogênio durante a atividade prolongada. Além disso, um aumento na produção de EROs pode reduzir a atividade de enzimas importantes do metabolismo celular incluindo a aconitase e a a-cetoglutarato desidrogenase, comprometendo a produção de energia oxidativa, via predominante na produção de ATP durante a atividade muscular prolongada.Fatigue is closely related to the depletion of glycogen in the skeletal muscle during prolonged exercise. Under this condition, the production of oxygen reactive species (ROS) is substantially increased. It has been shown that dietary supplementation of carbohydrate or antioxidant attenuates muscle fatigue during contraction. This suggests that glycogen availability and/or elevated ROS production plays an important role on muscle fatigue development during prolonged muscle activity. Although the mechanism is still unknown, we propose that elevated muscle glycogen availability may lead to a high activity of hexose monophosphate pathway, increasing the NADPH and glutathione concentration in the skeletal muscle tissue. Elevated antioxidant capacity would increase the muscle redox balance during muscle contraction, improving performance. In this process, the glucose-fatty acid cycle may be important to increase lipid oxidation and consequently decrease glycogen utilization during prolonged activity. In addition, an elevated ROS production could reduce the activity of key metabolic enzymes including aconitase and a-ketoglutarate dehydrogenase, decreasing the oxidative energy production in the skeletal muscle during prolonged activity.FAPESPCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CNP

Glutamine supplementation stimulates protein-synthetic and inhibits protein-degradative signaling pathways in skeletal muscle of diabetic rats.

In this study, we investigated the effect of glutamine (Gln) supplementation on the signaling pathways regulating protein synthesis and protein degradation in the skeletal muscle of rats with streptozotocin (STZ)-induced diabetes. The expression levels of key regulatory proteins in the synthetic pathways (Akt, mTOR, GSK3 and 4E-BP1) and the degradation pathways (MuRF-1 and MAFbx) were determined using real-time PCR and Western blotting in four groups of male Wistar rats; 1) control, non-supplemented with glutamine; 2) control, supplemented with glutamine; 3) diabetic, non-supplemented with glutamine; and 4) diabetic, supplemented with glutamine. Diabetes was induced by the intravenous injection of 65 mg/kg bw STZ in citrate buffer (pH 4.2); the non-diabetic controls received only citrate buffer. After 48 hours, diabetes was confirmed in the STZ-treated animals by the determination of blood glucose levels above 200 mg/dL. Starting on that day, a solution of 1 g/kg bw Gln in phosphate buffered saline (PBS) was administered daily via gavage for 15 days to groups 2 and 4. Groups 1 and 3 received only PBS for the same duration. The rats were euthanized, and the soleus muscles were removed and homogenized in extraction buffer for the subsequent measurement of protein and mRNA levels. The results demonstrated a significant decrease in the muscle Gln content in the diabetic rats, and this level increased toward the control value in the diabetic rats receiving Gln. In addition, the diabetic rats exhibited a reduced mRNA expression of regulatory proteins in the protein synthesis pathway and increased expression of those associated with protein degradation. A reduction in the skeletal muscle mass in the diabetic rats was observed and was alleviated partially with Gln supplementation. The data suggest that glutamine supplementation is potentially useful for slowing the progression of muscle atrophy in patients with diabetes

Involvement of Eukaryotic Translation Initiation Factor 5A (eIF5A) in Skeletal Muscle Stem Cell Differentiation

The eukaryotic translation initiation factor 5A (eIF5A) contains a special amino acid residue named hypusine that is required for its activity, being produced by a post-translational modification using spermidine as substrate. Stem cells from rat skeletal muscles (satellite cells) were submitted to differentiation and an increase of eIF5A gene expression was observed. Higher content of eIF5A protein was found in satellite cells on differentiation in comparison to non-differentiated satellite cells and skeletal muscle. The treatment with NI-guanyl- 1,7-diaminoheptane (GC7), a hypusination inhibitor, reversibly abolished the differentiation process. In association with the differentiation blockage, an increase of glucose consumption and lactate production and a decrease of glucose and palmitic acid oxidation were observed. A reduction in cell proliferation and protein synthesis was also observed. L-Arginine, a spermidine precursor and partial suppressor of muscle dystrophic phenotype, partially abolished the GC7 inhibitory effect on satellite cell differentiation. These results reveal a new physiological role for eIF5A and contribute to elucidate the molecular mechanisms involved in muscle regeneration.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)The State of Sdo Paulo Research Foundation (FAPESP)The National Council for Scientific and Technological Development (CNPq).Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq

Soleus cross-sectional area (µm²) analysis.

<p>The results are expressed as the means ± SEM. The values represent 6 animals/group. * <i>p</i><0.05, as indicated by the Anderson–Darling Normality Test. C = control rats; CS = control rats supplemented with glutamine; D = diabetic rats; DS = diabetic rats supplemented with glutamine.</p

Representative Western blots for total mTOR protein content (A); mTOR mRNA expression (B).

<p>The results are expressed as the means ± SEM. The values represent 6 animals/group. * <i>p</i><0.05, as indicated by ANOVA and the Bonferroni post-hoc test. C = control rats; CS = control rats supplemented with glutamine; D = diabetic rats; DS = diabetic rats supplemented with glutamine.</p

Plasma glutamine concentration (mM).

<p>The results are expressed as the means ± SEM. The values represent 6 animals/group. * <i>p</i><0.05, as indicated by ANOVA and Bonferroni post-hoc test. C = control rats; CS = control rats supplemented with glutamine; D = diabetic rats; DS = diabetic rats supplemented with glutamine.</p

Sequences of the primers, and annealing temperatures for the Real Time PCR of the genes studied.

<p>Sequences of the primers, and annealing temperatures for the Real Time PCR of the genes studied.</p